Viking Global Investors

Holding/activity history for  BridgeBio Pharma Inc. (BBIO)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2024   Q3 25,120,991 2.33 $25.46
2024   Q2 25,120,991 2.45 $25.33
2024   Q1 25,120,991 2.89 $30.92
2023   Q4 25,120,991 3.72 $40.37
2023   Q3 25,120,991 2.70 Reduce 5.63% 0.16 $26.37
2023   Q2 26,620,991 1.88 $17.20
2023   Q1 26,620,991 2.08 $16.58
2022   Q4 26,620,991 1.02 $7.62
2022   Q3 26,620,991 1.23 $9.94
2022   Q2 26,620,991 1.11 $9.08
2022   Q1 26,620,991 1.10 $10.15
2021   Q4 26,620,991 1.29 $16.68
2021   Q3 26,620,991 3.47 $46.87
2021   Q2 26,620,991 4.93 $60.96
2021   Q1 26,620,991 4.88 $61.60
2020   Q4 26,620,991 5.21 $71.11
2020   Q3 26,620,991 3.61 $37.52
2020   Q2 26,620,991 3.75 $32.61
2020   Q1 26,620,991 4.02 $29.00
2019   Q4 26,620,991 4.37 $35.05
2019   Q3 26,620,991 2.98 $21.47
2019   Q2 26,620,991 3.23 Buy 3.23 $26.97